Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)

NCT00095004 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

167

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: MK0462, rizatriptan benzoate / Duration of Treatment: 1day
DRUG: Comparator: placebo / Duration of Treatment: 1 day

Sponsor

Organon and Co